105
Participants
Start Date
October 8, 2024
Primary Completion Date
June 4, 2025
Study Completion Date
June 4, 2025
TAK-861
Oral tablet.
Placebo
TAK-861-matching placebo tablet.
Takeda Site 20, Helsinki
Takeda Site 24, Leuven
Takeda Site 12, Seoul
Takeda Site 23, Liège
Takeda Site 22, Linz
Takeda Site 3, Erpent
Takeda Site 25, Ghent
Takeda Site 14, Marseille
Takeda Site 10, Suwon
Takeda Site 16, Léon
Takeda Site 21, Tampere
Takeda Site 7, Bologna
Takeda Site 11, Seoul
Takeda Site 15, Nantes
Takeda Site 17, Pozzilli
Takeda Site 1, Glebe
Takeda Site 2, Alken
Takeda Site 4, Beijing
Takeda Site 27, Zhengzhou
Takeda Site 28, Shanghai
Takeda Site 26, Guangdong
Takeda Site 6, Bron
Takeda Site 5, Montpellier
Takeda Site 8, Roma
Takeda Site 9, Krakow
Takeda Site 13, Madrid
Takeda Site 19, Uppsala
28003, Barcelona
Lead Sponsor
Takeda
INDUSTRY